perindopril has been researched along with Cardiac Remodeling, Ventricular in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.13) | 18.2507 |
2000's | 23 (71.88) | 29.6817 |
2010's | 8 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Du, Q; Hakonarson, H; Hu, A; Liu, J; Wang, H; Wang, X; Wu, J; Xu, L; Zhang, J; Zhang, L; Zhang, Z | 1 |
Agmadova, ZM; Kallaeva, AN | 1 |
Bogachev, RS; Kober, DV; Kraĭtser, AP; Rfeenkova, VS | 1 |
Liskova, IuV; Salikova, SP; Stadnikov, AA | 1 |
Das, M | 1 |
Bodrug, NI; Butorov, IV; Butorov, SI; Krushka, SI | 1 |
Jia, M; Li, L; Liu, RY; Lu, PQ; Zhang, JY; Zhao, XY | 1 |
Ceconi, C; Chiariello, M; Decarli, A; Ferrari, R; Golcea, S; Nicolosi, GL; Parrinello, G; Remme, WJ; Tavazzi, L | 1 |
Bakaev, RG; Chudnovskaia, EA; Glazunov, AB; Kallaeva, AN; Kochetkov, BM; Moshkova, NK; Pekhtereva, DA; Strutynskiĭ, AV; Voronina, MA | 1 |
Chow, K; Ezekowitz, J; Haykowsky, M; Koshman, S; Mackey, JR; Oudit, G; Pagano, JJ; Paterson, I; Pituskin, E; Thompson, RB | 1 |
Bai, S; Cheng, Z; Liang, J; Xu, D | 1 |
Anderson, C | 1 |
Chen, CS; Hong, Y; Jin, BQ; Li, Y; Li, YN; Liu, XS; Ouyang, WM; Wang, XM | 1 |
Solignac, M | 1 |
Bozhko, AA; Kanorskiĭ, SG; Staritskiĭ, AG | 1 |
Akioka, K; Enomoto, S; Iwao, H; Izumi, Y; Kusuyama, T; Matsumoto, R; Nishiya, D; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
Ambrosio, G; Chiariello, M; Ferrari, R | 1 |
Chiariello, M; Ferrari, R; Magrini, G; Nicolosi, GL; Remme, P; Tavazzi, L | 1 |
Nicolosi, GL | 1 |
Bernocchi, P; Bettini, A; Ceconi, C; Ferrari, R; Gimbatti, OJ; Golcea, SS; Papa, K | 1 |
Ferrari, R | 1 |
Chen, J; He, AN; Hu, XY; Li, JH; Luo, RH; Wang, JA; Xie, XJ; Zhang, X | 1 |
Wang, JF; Wang, MH; Zhang, YL; Zhou, SX | 1 |
Kinugawa, S | 1 |
Bruining, N; de Feyter, PJ; de Winter, S; García-García, HM; Ligthart, JM; Rodriguez-Granillo, GA; Valgimigli, M | 1 |
Remme, WJ | 1 |
Crijns, HJ; Tuininga, YS; van Gelder, IC; van Veldhuisen, DJ; Wiesfeld, AC | 1 |
Abe, Y; Kimura, S; Matsuo, H; Mizushige, K; Murakami, K; Noma, T | 1 |
Chen, DG; Chen, SC; Rui, HB; Su, JZ; Wang, HJ; Wang, XY; Wu, KG | 1 |
McVeigh, GE | 1 |
Ito, T; Minami, S; Miyazaki, H; Mochizuki, S; Okazaki, F; Onodera, T; Seki, S; Taniguchi, I; Taniguchi, M | 1 |
6 review(s) available for perindopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Placebos; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke Volume; Survival Analysis; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2005 |
[Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Ventricular Remodeling | 2005 |
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
Effects of perindopril on cardiovascular remodeling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Perindopril; Vascular Resistance; Ventricular Remodeling | 2001 |
9 trial(s) available for perindopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Echocardiography, Doppler; Female; Humans; Male; Myocardial Infarction; Perindopril; Prognosis; Treatment Outcome; Ventricular Remodeling | 2009 |
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzu
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Apoptosis; Bisoprolol; Breast Neoplasms; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Perindopril; Placebos; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Research Design; Trastuzumab; Ventricular Remodeling | 2011 |
[Effect of different doses of perindopril on myocardial energy expenditure in patients with heart failure following myocardial infarction].
Topics: Aged; Energy Metabolism; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Perindopril; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2012 |
[Effects of perindopril on plasma soluble TRAIL and receptor soluble DR5 in patients with congestive heart failure].
Topics: Apoptosis; Heart Failure; Humans; Perindopril; Receptors, TNF-Related Apoptosis-Inducing Ligand; Ventricular Remodeling | 2003 |
[Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Retrospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Treatment Outcome; Ventricular Remodeling | 2006 |
Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Observer Variation; Perindopril; Regression Analysis; Treatment Outcome; Ultrasonography, Interventional; Ventricular Remodeling | 2007 |
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Double-Blind Method; Electrocardiography; Humans; Myocardial Infarction; Perindopril; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
PREAMI: Perindopril and Remodelling in Elderly with Acute Myocardial Infarction: study rationale and design.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Male; Myocardial Infarction; Perindopril; Research Design; Ventricular Remodeling | 2000 |
17 other study(ies) available for perindopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor.
Topics: Aged; Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Autoantibodies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Molecular Sequence Data; Perindopril; Prospective Studies; Receptor, Angiotensin, Type 1; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2013 |
[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].
Topics: Aged; Angina, Unstable; Aspirin; Benzopyrans; Cardiovascular Agents; Disease Progression; Drug Therapy, Combination; Echocardiography, Doppler; Ethanolamines; Female; Heart Failure; Humans; Male; Middle Aged; Nebivolol; Outcome Assessment, Health Care; Perindopril; Platelet Aggregation Inhibitors; Prognosis; Severity of Illness Index; Simvastatin; Time Factors; Ventricular Remodeling | 2014 |
[Clinical aspects of vaso-and cardioprotection in patients with primary and recurrent myocardial infarction].
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Vessels; Drug Combinations; Endothelium-Dependent Relaxing Factors; Femoral Artery; Heart Failure; Humans; Indapamide; Male; Middle Aged; Myocardial Infarction; Perindopril; Recurrence; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Color; Vasoconstriction; Ventricular Remodeling | 2014 |
[Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Disease Models, Animal; Extracellular Matrix; Heart Failure; Heart Ventricles; Male; Matrix Metalloproteinase 1; Melatonin; Models, Cardiovascular; Perindopril; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome; Ventricular Remodeling | 2014 |
Small benefits in trastuzumab-related cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Immunological; Bisoprolol; Breast Neoplasms; Cardiotoxicity; Female; Humans; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
[Treatment of cardiac insufficiency in patients with chronic obstructive lung disease].
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography, Doppler; Follow-Up Studies; Humans; Indapamide; Middle Aged; Perindopril; Pulmonary Disease, Chronic Obstructive; Pulmonary Heart Disease; Pulmonary Wedge Pressure; Time Factors; Treatment Outcome; Ventricular Function; Ventricular Remodeling | 2008 |
Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
Topics: Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2009 |
[Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Propanolamines; Time Factors; Treatment Outcome; Ventricular Remodeling | 2011 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is the key.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Stroke; Ventricular Remodeling | 2003 |
[Towards the optimal management in 2004 of patients with stable coronary artery disease].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Artery Disease; Europe; Humans; Myocardial Revascularization; Perindopril; Prognosis; Treatment Outcome; Ventricular Remodeling | 2004 |
Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chemokine CCL2; Echocardiography, Doppler; Male; Myocardial Infarction; Myocardium; Organ Size; Osteopontin; Perindopril; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Ventricular Remodeling | 2005 |
[The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Heart Failure; Humans; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Time Factors; Ventricular Remodeling | 2005 |
Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodelling in a rat model of acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow Cells; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesenchymal Stem Cell Transplantation; Myocardial Infarction; Myocardium; Perindopril; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling | 2006 |
[Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Heart; Male; Myocardial Infarction; Myocardium; Osteopontin; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2006 |
Effects of perindopril on left ventricular remodeling and aortic regurgitation in rats assessed by echocardiography.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Disease Models, Animal; Echocardiography, Doppler; Heart Ventricles; Male; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diuretics; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Perindopril; Propranolol; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride Symporter Inhibitors; Ventricular Remodeling | 1999 |
Perindopril reverses myocyte remodeling in the hypertensive heart.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Cell Count; Cell Size; Dose-Response Relationship, Drug; Echocardiography; Female; Heart; Hypertension; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2002 |